BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22166746)

  • 1. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
    Sikka K; Sharma SC; Thakar A; Dattagupta S
    J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
    Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
    J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
    Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
    Ecsedi S; Rákosy Z; Vízkeleti L; Juhász A; Sziklai I; Adány R; Balázs M
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some markers of proliferative activity in cholesteatoma epithelium in adults.
    Olszewska E; Chodynicki S; Chyczewski L; Rogowski M
    Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
    Olszewska E; Chodynicki S; Chyczewski L
    Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
    Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
    Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
    Welkoborsky HJ; Jacob RS; Hinni ML
    Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aural acquired cholesteatoma in children: surgical findings, recurrence and functional results.
    De Corso E; Marchese MR; Scarano E; Paludetti G
    Int J Pediatr Otorhinolaryngol; 2006 Jul; 70(7):1269-73. PubMed ID: 16488024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S; Tramier B; Strunski V
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
    Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.